← Open Payments lookup

UZMA ZAFAR: Open Payments

NPI 1770556185 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,173 in 61 payments from 10 companies in 2025. Trend: 2023 $346 · 2024 $836 · 2025 $1,173

Food & beverage: $1,173
CompanyPaymentsAmount
ABBVIE INC.23$457
Otsuka America Pharmaceutical, Inc.13$278
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$140
Takeda Pharmaceuticals U.S.A., Inc.3$76
Teva Pharmaceuticals USA, Inc.3$74
Vanda Pharmaceuticals Inc.2$53
Neurocrine BioSciences, Inc.3$49
Lundbeck LLC1$22
Supernus Pharmaceuticals, Inc.1$14
Neuronetics, Inc.1$10

Products named: VRAYLAR, REXULTI, CAPLYTA, TRINTELLIX, FANAPT, AUSTEDO XR, INGREZZA, ABILIFY MAINTENA.

Industry payments across NV — which companies pay providers there.